Asfotase alfa

  • Biologic
  • STRENSIQ

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Asfotase alfa: storage and handling

Refrigerate
Yes, as the label states
Label statement
STRENSIQ vials must be stored in the original carton until the time of use under refrigerated conditions at 2°C to 8°C (36°F to 46°F) and protected from light.
Freezing
Do not freeze
Label statement
DO NOT FREEZE OR SHAKE.
Room temperature
up to 3 hours
Label statement
Once removed from refrigeration, STRENSIQ should be administered within 3 hours.
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
STRENSIQ vials must be stored in the original carton until the time of use under refrigerated conditions at 2°C to 8°C (36°F to 46°F) and protected from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Beyond the room-temperature allowance the label states. The label does not state stability beyond it.

Entered: 1 day at up to 77°F (25°C).

Once removed from refrigeration, STRENSIQ should be administered within 3 hours.
Discard any unused product.

Contact the manufacturer about this product; the label text ClinDose has does not print a phone number for it.

All storage statements on the label (5)
  • STRENSIQ vials must be stored in the original carton until the time of use under refrigerated conditions at 2°C to 8°C (36°F to 46°F) and protected from light.
  • Once removed from refrigeration, STRENSIQ should be administered within 3 hours.
  • Do not use beyond the expiration date stamped on the carton.
  • DO NOT FREEZE OR SHAKE.
  • Discard any unused product.

FDA label version 18, effective December 12, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.